Anzahl der Publikationen: 4
2023
Käsmann, Lukas; Eze, Chukwuka; Taugner, Julian; Nieto, Alexander; Hofstetter, Kerstin; Kröninger, Sophie; Guggenberger, Julian; Kenndoff, Saskia; Flörsch, Benedikt; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2023):
Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 10: S. 7393-7403
[PDF, 1MB]
2022
Eze, Chukwuka ORCID: https://orcid.org/0000-0003-3779-1398; Guggenberger, Julian Elias; Schmidt-Hegemann, Nina-Sophie; Kenndoff, Saskia; Taugner, Julian; Käsmann, Lukas; Schönecker, Stephan; Floersch, Benedikt; Li, Minglun; Belka, Claus und Manapov, Farkhad
(2022):
Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve.
In: Cancer, Bd. 128, Nr. 12: S. 2358-2366
[PDF, 220kB]
Flörsch, Benedikt; Taugner, Julian; Käsmann, Lukas; Kenndoff, Saskia; Guggenberger, Julian; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad
(2022):
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy +/- immune checkpoint inhibition: a decade-long single-center historical analysis.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 7: S. 3267-3276
[PDF, 1MB]
Käsmann, Lukas; Taugner, Julian; Eze, Chukwuka; Nieto, Alexander; Pelikan, Carolyn; Flörsch, Benedikt; Kenndoff, Saskia; Hofer, Thomas P.; Nössner, Elfriede; Schulz, Christian; Unterrainer, Marcus; Tufman, Amanda; Klauschen, Frederick; Jung, Andreas; Neumann, Jens; Kumbrink, Jorg; Reinmuth, Niels; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad
(2022):
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study.
In: Translational Lung Cancer Research, Bd. 11, Nr. 7: S. 1503-1509
[PDF, 294kB]
Diese Liste wurde am
Sat Nov 23 21:53:16 2024 CET
erstellt.